Company news
Mirum Pharmaceuticals, Inc. news in 2020
Mirum Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Mirum Pharmaceuticals Announces Virtual Investor Day 2020
December 6, 2020
Mirum Pharmaceuticals Announces European Medicines Agency Validation of the Marketing Authorization Application for Maralixibat in Patients with PFIC2
November 29, 2020
Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with Maralixibat
November 14, 2020
Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor Day
November 11, 2020
Mirum Pharmaceuticals Broadens Expanded Access Program for Maralixibat in Alagille Syndrome to Europe and Australia
November 4, 2020
Mirum Pharmaceuticals Announces New Data Being Presented in Late-Breaker Oral and Poster Presentations at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
November 1, 2020
Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States
October 14, 2020
Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome and Launches Expanded Access Program
August 31, 2020
Mirum Pharmaceuticals Presents Maralixibat Five-Year Transplant-Free Survival Data for Patients With PFIC2 at Digital International Liver Congress 2020
August 28, 2020
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
August 5, 2020
Mirum’s Maralixibat Demonstrates Transplant-Free Survival for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
June 1, 2020
Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
May 6, 2020
Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer
April 27, 2020
Mirum Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
March 11, 2020
Mirum Pharmaceuticals Promotes Ian Clements to Chief Financial Officer
January 13, 2020
Mirum Pharmaceuticals Announces Pricing of Public Offering
January 7, 2020